Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06074731

Enrollment

500

Registered

2023-10-10

Start date

2017-06-01

Completion date

2026-12-31

Last updated

2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy, Macular Degeneration, Retinal Disease

Brief summary

In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and future possible influence on disease management for patients affected by those diseases.

Interventions

DIAGNOSTIC_TESTSS-OCT system Plex Elite 9000

We will use a commercially available SS-OCT system (Plex Elite 9000; Carl Zeiss Meditec).

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

5 Years to 110 Years

Healthy volunteers

Yes

Inclusion criteria

* Age between 5 and 110 years * Ability to follow instructions during imaging procedure * Written Informed consent

Exclusion criteria

* Dementia * Inability to follow instructions during imaging procedure * Patients who do not give informed consent

Design outcomes

Primary

Measure	Time frame	Description
Morphological changes using Swept Source Optical Coherence Tomography	through study completion, an average of 1 year	Morphological changes in retinal diseases provided by Swept Source Optical

Countries

Austria

Contacts

Primary ContactMatthias Bolz, Prof. Dr.

matthias.bolz@kepleruniklinikum.at+43 (0)5 7680 83 - 1050

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026